Nationwide recall issued for this thyroid medication. See products
Major Rugby Announces Nationwide Recall of Levothyroxine Sodium Tablets
Cybersecarmor.com – Pharmaceutical company Major Rugby has initiated a comprehensive recall affecting multiple packages of its levothyroxine sodium tablets, which are widely prescribed for thyroid-related conditions. The recall announcement was communicated to retail partners through a formal letter dispatched earlier this month, alerting pharmacies and medical supply stores to the situation.
Understanding the Recall Scope
The pharmaceutical manufacturer has identified twelve distinct product packages that fall under the recall notice. These affected items include both individual consumer packs containing ten tablets and larger retail boxes that hold ten blister-packed units. The tablets are marketed under two brand names—Major and Cardinal—and have been available across the United States since January 2025, according to documentation provided in the recall correspondence.
Levothyroxine sodium serves as a critical treatment for several medical conditions. The Mayo Clinic, a leading medical research institution, confirms that this medication addresses hypothyroidism, which occurs when the thyroid gland produces insufficient hormones. Additionally, the drug helps manage enlarged thyroid glands and certain forms of thyroid cancer. Patients relying on this medication for ongoing treatment may want to verify whether their current supply is among the affected packages.
What Consumers Need to Know
While the recall has been issued, Major Rugby has emphasized that the situation does not represent an immediate safety emergency. In its communication to retailers, the company stated that patients who continue taking the recalled tablets "is not likely to cause adverse health effects." This reassurance comes alongside a recommendation that consumers return their medication to the original point of purchase for proper handling.
"is not likely to cause adverse health effects"
The primary concern driving this recall involves the potency of the tablets. According to both the company's letter and a subsequent report from the Food and Drug Administration, the affected pills are classified as "subpotent." This designation means the tablets contain less active medication than their labeled dosage indicates. For patients requiring precise hormone levels, this discrepancy could potentially affect treatment outcomes over time.
Identifying Affected Products
All twelve recalled packages require a prescription for purchase. The affected products span multiple dosage strengths, each available in different packaging configurations. The following list details every package included in the recall:
Products containing 100 tablets, organized as ten unit-dose blisters of ten tablets each:
- 25 mcg (0.025 mg)
- 50 mcg (0.050 mg)
- 75 mcg (0.075 mg)
- 88 mcg (0.088 mg)
- 112 mcg (0.0112 mg)
- 125 mcg (0.0125 mg)
- 150 mcg (0.0150 mg)
Products containing 10 tablets, organized as ten unit-dose blisters of one tablet each:
- 25 mcg (0.025 mg)
- 50 mcg (0.050 mg)
- 125 mcg (0.0125 mg)
- 150 mcg (0.0150 mg)
Next Steps for Patients
Consumers who discover any of these products in their medicine cabinet should consider consulting their healthcare provider. Physicians can help determine whether the subpotency issue might impact individual treatment plans and advise on appropriate next steps. Patients may also wish to contact their pharmacy to confirm whether their current prescription is among the recalled packages.
The recall represents a proactive measure by Major Rugby to ensure product quality and patient safety. While the tablets remain safe for continued use, the reduced potency means patients should be aware of the situation and maintain open communication with their healthcare team.
Drew Pittock covers national trending news for USA TODAY. He can be reached at DPittock@usatodayco.com.
Related Reading
Frequently Asked Questions
What is Nationwide recall issued for this thyroid?Nationwide recall issued for this thyroid is the main topic of this guide. The article explains the context, practical details, and next steps readers should understand.
Why does Nationwide recall issued for this thyroid matter?Nationwide recall issued for this thyroid matters because readers are looking for a useful answer, not just a short summary. Good content should match search intent and help them decide what to do next.